Peter G. Edwards - 08 Mar 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role
GENERAL COUNSEL
Signature
/s/ Jeffrey Hamet, Attorney-in-Fact for Peter G. Edwards
Issuer symbol
ELUT
Transactions as of
08 Mar 2022
Transactions value $
$0
Form type
4
Filing time
10 Mar 2022, 19:33:27 UTC
Previous filing
01 Sep 2021
Next filing
12 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELUT Stock Option (Right to Buy) Award $0 +31K $0.00 31K 08 Mar 2022 Class A Common Stock 31K $5.08 Direct F1
transaction ELUT Restricted Stock Units Award $0 +8.7K $0.00 8.7K 08 Mar 2022 Class A Common Stock 8.7K Direct F2, F3
transaction ELUT Restricted Stock Units Award $0 +4.63K $0.00 4.63K 08 Mar 2022 Class A Common Stock 4.63K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026.
F2 Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.
F3 The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024.
F4 The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.